Prenatal genetic screening can offer soon-to-be parents and those considering parenthood information about the chance of passing on certain conditions to their child, allowing women and their partners to make informed decisions about planning their family, pregnancy management, and future child-rearing. A variety of tools and methods are available for prenatal screenings — all with a goal of gaining insight into the potential outcome of certain genetic conditions.
Noninvasive prenatal screening (NIPS) assesses risk for a chromosomal aneuploidy – when there are extra or missing chromosomes in fetal DNA. The most common conditions screened through NIPS are Down Syndrome, Edwards Syndrome, and Turner Syndrome. The procedure takes a blood sample from a pregnant mother to examine cell-free DNA from the placenta that circulates in the mother’s blood.
Noninvasive Prenatal Screening is part of the SWHR Maternal Health Network, which engages the following focus areas: Expanded Carrier Screening, Fertility, Maternal & Infant Health Disparities, and Noninvasive Prenatal Screening.
Guides & Toolkits
The NIPS Resource Guide can help provided education and information about the process, risks, and benefits of NIPS, helping give...
Fact Sheets
This genetic screening poster focuses on two types of screens, Expanded Carrier Screening and Noninvasive Prenatal Screening, as well as...
Prenatal genetic screening can be a helpful tool for future parents to make informed decisions about their health care. SWHR spoke with two experts at the National Society of Genetic Counselors (NSGC) about genetic screening.
The Noninvasive Prenatal Screening (NIPS) Resource Guide for Women was created to help pregnant individuals navigate conversations with providers and professionals about their prenatal screening options.
The Genetic Screening Roadmap aims to assist maternal health clinicians in framing and providing genetic screening for women.
SWHR convened a diverse working group of clinicians, genetic counselors, patient advocates, policy professionals, and industry representatives for a three-day roundtable meeting on eliminating barriers to access and, by extension, reducing health disparities in prenatal care as they relate to ECS and NIPS.
Alopecia Areata – Alzheimer’s Disease – Atopic Dermatitis – Autoimmune Diseases – Bone Health – Diagnostics – Endometriosis – Expanded Carrier Screening – Eye Health – Fertility – Heart Health – HPV & Related Diseases – Liver Health – Lupus – Maternal and Infant Health Disparities – Menopause – Migraine – Narcolepsy – Noninvasive Prenatal Screening – Obesity – Polycystic Ovary Syndrome – Psoriatic Arthritis – Sleep Health – Urology – Uterine Fibroids – Vaccines
